|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
ELN » Topics » To holders of Ordinary Shares and B Executive Shares and, for information only, to the holder of the Executive Shares.This excerpt taken from the ELN 6-K filed Jun 23, 2009. To
holders of Ordinary Shares and B Executive Shares
and, for information
only, to the holder of the Executive Shares.
Dear Shareholder
The annual general meeting (the AGM or the
Meeting) of the Company will be held at the
Davenport Hotel, Dublin 2, Ireland at 10.00am on Thursday,
July 16, 2009. The notice of the Meeting is attached and
you are cordially invited to attend.
The ordinary business to be transacted at the Meeting is
referred to in Resolutions 1 to 13. Under the terms of our
articles of association, directors serve for a term of three
years expiring at the annual general meeting in the third year
following their election, or as the case may be, their
re-election at an AGM. Additionally, in line with the provisions
of the Combined Code, non-executive directors who have served on
the board for in excess of nine years are subject to annual
re-election by shareholders. As a result of both of these
requirements, Shane Cooke, Lars Ekman, Gary Kennedy, Kelly
Martin, Kieran McGowan and myself are standing for re-election
at this years AGM. Patrick Kennedy and Donal OConnor
who were appointed to the board since last years AGM are
standing for election. Additionally, the Board is proposing the
election of Vaughn Bryson, Richard Pilnik and Jack Schuler as
directors of the Company with effect from end of the AGM.
Floyd Bloom, Ann Gray and Dennis Selkoe will retire from the
board at the conclusion of the AGM. I would like to thank Floyd,
Ann and Dennis for their many contributions to the development
of Elan over a large number of years and, in particular, to
mention the contribution of Dennis who was a founder director of
Athena Neurosciences, Inc in 1986 and which we acquired in 1996.
I am delighted that both Dennis and Floyd have agreed to
continue to be involved with the Company in the future by
sitting on our Science & Technology Committee. These
changes continue the process of change and renewal of the Board,
and in particular, represent an infusion of commercial
pharmaceutical experience which is most welcome.
The Board has reviewed the performance of each director standing
for re-election and confirms that they continue to contribute
effectively and demonstrate commitment to the role and therefore
recommends that shareholders vote in favour of their
re-election. In December 2008, the board reviewed the
independence of each of the independent directors, including
those who have served for more than nine years, and it
affirmatively determined that each of them was considered to be
independent in accordance with the terms of the Companys
corporate governance guidelines. A biography of each of the
existing directors standing for election or re-election is
contained on pages 85 to 87 of the annual report. The biography
of the new directors standing for election was included in the
announcement of their appointments.
The Directors propose that the special business as set out in
Resolutions 14 to 20 in the notice be transacted at the Meeting
for the purposes as set out below.
This excerpt taken from the ELN 6-K filed Mar 31, 2008. To
holders of Ordinary Shares and B Executive Shares
and,
for information only, to the holder of the Executive Shares.
Dear Shareholder
The annual general meeting (the AGM or the
Meeting) of the Company will be held at the
Shelbourne Hotel, Dublin 2, Ireland at 10.00am on Thursday,
May 22, 2008. The notice of the Meeting is attached and you
are cordially invited to attend.
The ordinary business to be transacted at the Meeting is
referred to in Resolutions 1 to 10. Under the terms of our
articles of association, directors serve for a term of three
years expiring at the annual general meeting in the third year
following their election, or as the case may be, their
re-election at an AGM. Additionally, in line with the provisions
of the Combined Code, non-executive directors who have served on
the board for in excess of nine years are subject to annual
re-election by shareholders. As a result of both of these
requirements, Ann Gray, Kieran McGowan, Kyran McLaughlin and
Dennis Selkoe are standing for re-election at this years
AGM. Floyd Bloom, Jonas Frick, Giles Kerr and Jeff Shames who
were appointed to the board since last years AGM are
standing for election. Laurence Crowley will not be seeking
re-election and so will retire from the Board at the conclusion
of 2008 AGM. Laurence has served on the Board and a number of
Board committees since 1994 and we will all miss his presence
greatly.
The Board has reviewed the performance of each director standing
for re-election and confirms that they continue to contribute
effectively and demonstrate commitment to the role and therefore
recommends that shareholders vote in favour of their
re-election. In December 2007, the board reviewed the
independence of each of the then non-executive directors,
including those who have served for more than nine years, and it
affirmatively determined that each of them was considered to be
independent in accordance with the terms of the Companys
corporate governance guidelines. A biography of each director
standing for election or re-election is contained on
pages 53 and 54 of the annual report. The changes in the
Board composition in the past year is part of the task of
renewing and rebalancing the composition of the Board I set
myself when I became chairman in 2005.
The Directors propose that the special business as set out in
Resolutions 11 to 15 in the notice be transacted at the Meeting
for the purposes as set out below.
This excerpt taken from the ELN 6-K filed Mar 30, 2007. To
holders of Ordinary Shares and B Executive Shares
and, for information
only, to the holder of the Executive Shares.
Dear Shareholder
The annual general meeting (the AGM or the
Meeting) of the Company will be held at The Four
Seasons Hotel, Ballsbridge, Dublin 4, Ireland at 10.00am on
Thursday, May 24, 2007. The notice of the Meeting is
attached and you are cordially invited to attend.
The ordinary business to be transacted at the Meeting is
referred to in Resolutions 1 to 6. Under the terms of our
articles of association, directors serve for a term of three
years expiring at the annual general meeting in the third year
following their election, or as the case may be, their
re-election at an AGM. Additionally, in line with the provisions
of the Combined Code, non-executive directors who have served on
the board for in excess of nine years are subject to annual
re-election by shareholders. Therefore, Laurence Crowley, Alan
Gillespie, Dennis Selkoe and I will retire at this years
AGM. Laurence Crowley, Dennis Selkoe and I, being eligible, are
standing for re-election. Alan Gillespie will not be seeking
re-election and so will retire from the conclusion of the 2007
Annual General Meeting. Alan has served on the Board since 1996
and I would like to thank him for his very significant
contribution over these years. William Rohn, who was appointed
to the board after last years AGM is standing for
election. The Board has reviewed the performance of each
director standing for re-election and confirms that they
continue to contribute effectively and demonstrate commitment to
the role and therefore recommends that shareholders vote in
favour of their re-election. In December 2006, the board
reviewed the independence of each of the non-executive
directors, including those who have served for more than nine
years, and it affirmatively determined that each of them was
considered to be independent in accordance with the terms of the
Companys corporate governance guidelines. A biography of
each director standing for election or re-election is contained
on pages 50 to 51 of the annual report.
The Directors propose that the special business as set out in
Resolutions 7 to 10 in the notice be transacted at the Meeting
for the purposes as set out below.
| EXCERPTS ON THIS PAGE:
|
| |||||||